Last checked at 20 Oct 2020 12:30
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 19 October 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities |
|
|
|
|
2,725,003 | 2.11% | 467,612 | 0.36% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
362,656 | 0.28% | 554,016 | 0.43% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
3,087,659 | 2.40% | 1,021,628 | 0.79% | ||
|
|
|
| ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 8 | 212.9300 USD |
Purchase | 14 | 215.4685 USD |
Purchase | 100 | 216.3500 USD |
Purchase | 104 | 216.9709 USD |
Purchase | 125 | 215.8905 USD |
Purchase | 146 | 213.1036 USD |
Purchase | 147 | 212.5585 USD |
Purchase | 173 | 212.6000 USD |
Purchase | 200 | 216.2300 USD |
Purchase | 212 | 212.7247 USD |
Purchase | 212 | 214.1200 USD |
Purchase | 252 | 214.8979 USD |
Purchase | 281 | 213.0440 USD |
Purchase | 300 | 215.7700 USD |
Purchase | 372 | 213.6736 USD |
Purchase | 393 | 216.1544 USD |
Purchase | 394 | 213.6568 USD |
Purchase | 531 | 213.5214 USD |
Purchase | 536 | 214.5205 USD |
Purchase | 681 | 212.9148 USD |
Purchase | 733 | 214.4670 USD |
Purchase | 783 | 213.3297 USD |
Purchase | 991 | 213.7579 USD |
Purchase | 1,338 | 214.6223 USD |
Purchase | 1,495 | 212.7100 USD |
Purchase | 1,537 | 213.4091 USD |
Purchase | 2,446 | 213.5794 USD |
Purchase | 2,664 | 216.2897 USD |
Purchase | 2,913 | 214.6555 USD |
Purchase | 3,504 | 214.9815 USD |
Purchase | 4,250 | 215.4404 USD |
Purchase | 4,807 | 215.0284 USD |
Purchase | 5,076 | 215.0155 USD |
Purchase | 6,619 | 215.3456 USD |
Purchase | 10,140 | 215.1544 USD |
Purchase | 11,600 | 216.2569 USD |
Purchase | 15,601 | 214.8073 USD |
Purchase | 30,858 | 212.7831 USD |
Sale | 18 | 214.6916 USD |
Sale | 19 | 214.6673 USD |
Sale | 31 | 215.8670 USD |
Sale | 44 | 213.5195 USD |
Sale | 51 | 215.1541 USD |
Sale | 61 | 216.3600 USD |
Sale | 100 | 212.8750 USD |
Sale | 100 | 216.3500 USD |
Sale | 100 | 216.3200 USD |
Sale | 130 | 213.5815 USD |
Sale | 139 | 215.9589 USD |
Sale | 160 | 212.7338 USD |
Sale | 171 | 215.9140 USD |
Sale | 200 | 214.4150 USD |
Sale | 217 | 215.8378 USD |
Sale | 300 | 214.6500 USD |
Sale | 302 | 216.1037 USD |
Sale | 393 | 216.1544 USD |
Sale | 400 | 215.6550 USD |
Sale | 954 | 216.1733 USD |
Sale | 1,935 | 212.7100 USD |
Sale | 3,054 | 214.9586 USD |
Sale | 5,059 | 214.9433 USD |
Sale | 5,352 | 216.1792 USD |
Sale | 6,167 | 215.7344 USD |
Sale | 6,794 | 215.2049 USD |
Sale | 10,100 | 212.7233 USD |
Sale | 12,700 | 215.0161 USD |
Sale | 20,977 | 212.8135 USD |
Sale | 36,662 | 214.8314 USD |
(b) Derivatives transactions (other than options transactions)
Product Name | Nature of transaction | Number of relevant securities | Price per |
|
|
| unit |
SWAP | Short | 35,122 | 214.9545 USD |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | NO |
| Date of disclosure: | 20 Oct 2020 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
View source version on businesswire.com: https://www.businesswire.com/news/home/20201020005666/en/
Copyright Business Wire 2020